Iva Igracki

Company: Glenmark Pharmaceuticals

Job title: Director, Medical Affairs Europe, Global Medical Lead, Innovative Dermatology Portfolio

Seminars:

Workshop B: Strategic Decision-Making & Closing the Gap in Dermatology 11:25 am

The immunodermatology landscape is rapidly evolving with new targets, modalities, and deeper pathway insights. Success depends not only on selecting the “right” targets and building a future-ready pipeline but also on ensuring that approved therapies reach eligible patients. This integrated session brings together strategic R&D decision-making and real-world implementation challenges to provide a holistic view…Read more

day: Pre-Conference Day

Panel Discussion: Can Topical and Systemic Therapies Each Find Their Place in the Future of Dermatology Drug Development? 4:30 pm

How should we balance the clinical and commercial drivers behind topical and systemic innovation, especially as realworld prescribing habits continue to favor topicals? How are these approaches viewed from the patient, regulator and investor perspective? Which factors, including disease severity, body surface area, and treatment setting, best guide whether a topical, systemic, or combination approach…Read more

day: Day One PM